Criteria | TL PD | Focality of Progressive Lesions | NTL PD | NL PD | New Organ Lesion | PMD |
---|
Uni | Oligo | Multi | Total | Nodal | Extra-nodal | Both |
---|
Lugano | 10 | 4 | 1 | 5 | 3 | 7 | 2 | 1 | 4 | Bone (3) Muscle (3) Peritoneal (2) Fat tissue Kidney Liver Lung Pancreas Pleura | 2 |
Cheson | 10 | 4 | 1 | 5 | 3 | 7 | 2 | 1 | 4 | 0 |
RECIL | 7 | 1 | 1 | 5 | 0 | 7 | 2 | 1 | 4 | 0 |
LYRIC | 6 | 0 | 1 | 5 | 1 | 6 | 1 | 1 | 4 | 0 |
- Comparison of different imaging response criteria and the reasons for progressive disease. Shown are patient numbers with uni, oligo or multi target lesion (TL) progression, non-target lesion (NTL) progression, appearance of new lesions (NL) and progressive metabolic disease (PMD). Overlap of progression by multiple causes occurred in 53.8% of progressive patients by Lugano criteria, in 54.5% of patients by Cheson criteria, in 57.1% by RECIL, and 85.7% by LYRIC.